Open Science Research Excellence

ICDDCE 2020 : International Conference on Drug Discovery in Cancer Epigenetics

Bali, Indonesia
July 16 - 17, 2020

Call for Papers

ICDDCE 2020 : International Conference on Drug Discovery in Cancer Epigenetics is the premier interdisciplinary platform for the presentation of new advances and research results in the fields of Drug Discovery in Cancer Epigenetics. The conference will bring together leading academic scientists, researchers and scholars in the domain of interest from around the world. Topics of interest for submission include, but are not limited to:
  • Drug discovery in cancer epigenetics
  • Epigenetic mechanisms and phenomena
  • Cancer epigenetics
  • Methods and tools for epigenetic drug development
  • Drug discovery methods
  • Preclinical cancer models and clinical response
  • Discovery of biomarkers for drug development
  • Networks and consortia for epigenetic drug discovery
  • Classes of epigenetic drugs
  • DNA Methyltransferase Inhibitors
  • Small molecule inhibitors of Histone Deacetylases and Acetyltransferases
  • The development of selective methyltransferase and demethylase inhibitors
  • Bromodomains as anti-cancer targets
  • Epigenetic readers interpreting the Lysine Methylome
  • Non coding RNAs: clinical and therapeutic applications
  • Clinical implications of epigenetic therapy
  • Clinical applications of epigenetic drugs
  • Efficacy of combined epigenetic therapies
  • Predicting and monitoring responses to epigenetic drugs
  • Episensitization
  • The emerging potential for epigenetic therapeutics in non-cancer disorders